Incidence and Costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014

Pediatrics

Volumn 141, Issue 4, 2018, Pages

  Winkelman, Tyler N A ^a,b   Villapiano, Nicole ^c   Kozhimannil, Katy B ^d   Davis, Matthew M ^e,f   Patrick, Stephen W ^g,h  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c Guthrie Cortland Regional Medical Center   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Department of Neurology   (United States)

^h VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFANT; LENGTH OF STAY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAID; MORBIDITY; NEONATAL ABSTINENCE SYNDROME; PRIORITY JOURNAL; TREND STUDY; UNITED STATES; CROSS-SECTIONAL STUDY; ECONOMICS; NEWBORN; TRENDS;

CROSS-SECTIONAL STUDIES; FEMALE; HOSPITAL COSTS; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; MEDICAID; NEONATAL ABSTINENCE SYNDROME; UNITED STATES;

EID: 85044763848     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2017-3520     Document Type: Article

References (35)

1. Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):667
2. Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome-28 states, 1999-2013. MMWR Morb Mortal Wkly Rep. 2016;65(31):799-802
3. Villapiano NLG, Winkelman TNA, Kozhimannil KB, Davis MM, Patrick SW. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatr. 2017;171(2):194-196
4. McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med. 2016;375(25):2468-2479
5. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18): 1934-1940
6. Patrick SW, Burke JF, Biel TJ, Auger KA, Goyal NK, Cooper WO. Risk of hospital readmission among infants with neonatal abstinence syndrome. Hosp Pediatr. 2015;5(10):513-519
7. Tolia VN, Patrick SW, Bennett MM, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 2015;372(22):2118-2126
8. Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the United States. Addiction. 2017;112(9):1590-1599
9. Okoroh EM, Gee RE, Jiang B, McNeil MB, Hardy-Decuir BA, Zapata AL. Neonatal abstinence syndrome: Trend and expenditure in Louisiana Medicaid, 2003-2013. Matern Child Health J. 2017;21(7):1479-1487
10. 114th United States Congress. Comprehensive addiction and recovery act of 2016. 2016. Available at: Https://www.congress. gov/bill/114th-congress/senate-bill/524/text. Accessed June 6, 2017
11. United States Government Accountability Office. Newborn health: Federal action needed to address neonatal abstinence syndrome. 2017. Available at: Https://www.gao. gov/assets/690/687580. pdf. Accessed October 20, 2017
12. Agency for Healthcare Research and Quality. Healthcare cost and utilization project (HCUP) databases. 2017. Available at: Www.hcup-us. ahrq. gov/databases. jsp. Accessed April 25, 2017
13. Bureau of Labor Statistics. Table 24. Historical consumer price index for all urban consumers (CPI-U): U.S. city average, all items. 2017. Available at: Https://www.bls. gov/cpi/tables/historical-cpi-u-201710. pdf. Accessed December 10, 2017
14. Patrick SW. The triple aim for neonatal abstinence syndrome. J Pediatr. 2015;167(6):1189-1191
15. Center for Medicare and Medicaid Services. Reducing Early Elective Deliveries in Medicaid and CHIP. Baltimore, MD: Center for Medicare and Medicaid Services; 2012. Available at: Https://www.medicaid. gov/medicaid/quality-of-care/downloads/eed-brief. pdf. Accessed December 11, 2017
16. Holmes AV, Atwood EC, Whalen B, et al. Rooming-in to treat neonatal abstinence syndrome: Improved family-centered care at lower cost. Pediatrics. 2016;137(6):e20152929
17. Hall ES, Wexelblatt SL, Crowley M, et al. OCHNAS Consortium. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014;134(2). Available at: Www.pediatrics.org/cgi/content/full/134/2/e527
18. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician. 2007;53(10):1722-1730
19. Hünseler C, Brückle M, Roth B, Kribs A. Neonatal opiate withdrawal and rooming-in: A retrospective analysis of a single center experience. Klin Padiatr. 2013;225(5):247-251
20. Saiki T, Lee S, Hannam S, Greenough A. Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. Eur J Pediatr. 2010;169(1):95-98
21. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006;117(6). Available at: Www.pediatrics.org/cgi/content/full/117/6/e1163
22. Welle-Strand GK, Skurtveit S, Jones HE, et al. Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009. Drug Alcohol Depend. 2013;127(1-3):200-206
23. Kraft WK, Adeniyi-Jones SC, Chervoneva I, et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. N Engl J Med. 2017;376(24):2341-2348
24. Krans EE, Cochran G, Bogen DL. Caring for opioid-dependent pregnant women: Prenatal and postpartum care considerations. Clin Obstet Gynecol. 2015;58(2):370-379
25. Burns L, Mattick RP, Lim K, Wallace C. Methadone in pregnancy: Treatment retention and neonatal outcomes. Addiction. 2007;102(2):264-270
26. Ordean A, Kahan M, Graves L, Abrahams R, Kim T. Obstetrical and neonatal outcomes of methadonemaintained pregnant women: A Canadian multisite cohort study. J Obstet Gynaecol Can. 2015;37(3):252-257
27. Fullerton CA, Kim M, Thomas CP, et al. Medication-assisted treatment with methadone: Assessing the evidence. Psychiatr Serv. 2014;65(2): 146-157
28. Thomas CP, Fullerton CA, Kim M, et al. Medication-assisted treatment with buprenorphine: Assessing the evidence. Psychiatr Serv. 2014;65(2):158-170
29. 114th United States Congress. 21st century cures act. 2016. Available at: Https://www.congress.gov/bill/114thcongress/house-bill/34/text. Accessed June 6, 2016
30. Ko JY, Wolicki S, Barfield WD, et al. CDC grand rounds: Public health strategies to prevent neonatal abstinence syndrome. MMWR Morb Mortal Wkly Rep. 2017;66(9):242-245
31. Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105(10):1776-1782
32. Sung H-E, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. J Adolesc Health. 2005;37(1):44-51
33. Spiller H, Lorenz DJ, Bailey EJ, Dart RC. Epidemiological trends in abuse and misuse of prescription opioids. J Addict Dis. 2009;28(2):130-136
34. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev. 2007;26(5):487-492
35. Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241-248